Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study.

Tim A.C. de Vries,Martin E.W. Hemels,Frank Cools,Harry J.G.M. Crijns,Laetitia Yperzeele,Peter Vanacker,Ivan Blankoff,Patrizio Lancellotti,Georges H. Mairesse,Anne de Veer,Ruben Casado-Arroyo,Emmanuel Catez,Michel De Pauw,Thomas Vanassche,Carlo de Asmundis,Paulus Kirchhof,Raffaele De Caterina,Joris R. de Groot,ETNA-AF-Europe principal investigators from Belgium

Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study.

2021

Tim A.C. de Vries
Martin E.W. Hemels
Frank Cools
Harry J.G.M. Crijns
Laetitia Yperzeele
Peter Vanacker
Ivan Blankoff
Patrizio Lancellotti
Georges H. Mairesse
Anne de Veer
Ruben Casado-Arroyo
Emmanuel Catez
Michel De Pauw
Thomas Vanassche
Carlo de Asmundis
Paulus Kirchhof
Raffaele De Caterina
Joris R. de Groot
ETNA-AF-Europe principal investigators from Belgium

Studies on the use of non-vitamin K antagonist oral anticoagulants in unselected patients with atrial fibrillation (AF) show that clinical characteristics and dosing practices differ per region, bu...

Keywords:

Stroke
dose reduction
Internal medicine
Dosing
Off-label use
Atrial fibrillation
Edoxaban
Diabetes mellitus
Renal function
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations